| Literature DB >> 25746296 |
Shukriti Sharma1, Chistine Citti2, Eveline Sagné2, Marc S Marenda1, Philip F Markham1, Glenn F Browning1.
Abstract
Mycoplasma bovis is a cause of pneumonia, mastitis, arthritis and otitis media in cattle throughout the world. However, despite its clinical significance, there is a paucity of tools to genetically manipulate it, impeding our capacity to further explore the molecular basis of its virulence. To address this limitation, we developed a series of homologous and heterologous replicable plasmids from M. bovis and M. agalactiae. The shortest replicable oriC plasmid based on the region downstream of dnaA in M. bovis was 247 bp and contained two DnaA boxes, while oriC plasmids based on the region downstream of dnaA in M. agalactiae strains 5632 and PG2 were 219 bp and 217 bp in length, respectively, and contained only a single DnaA box. The efficiency of transformation in M. bovis and M. agalactiae was inversely correlated with the size of the oriC region in the construct, and, in general, homologous oriC plasmids had a higher transformation efficiency than heterologous oriC plasmids. The larger pWholeoriC45 and pMM21-7 plasmids integrated into the genomic oriC region of M. bovis, while the smaller oriC plasmids remained extrachromosomal for up to 20 serial passages in selective media. Although specific gene disruptions were not be achieved in M. bovis in this study, the oriC plasmids developed here could still be useful as tools in complementation studies and for expression of exogenous genes in both M. bovis and M. agalactiae.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25746296 PMCID: PMC4351888 DOI: 10.1371/journal.pone.0119000
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Oligonucleotide pairs used to generate and assess oriC plasmids.
| Oligonucleotides | Sequence (5’-3’) | PCR product (size) | Reference (nucleotide sequence) |
|---|---|---|---|
| OMBIRL for | tcttgattactgttgcttga | IRL region of | NC_014760.1 (1003214 to 0000048) |
| OMBIRL rev | aaagcaatttccttatcatt | ||
| OMBIRR for | caacgagatttttaagaaaag | IRR region of | NC_014760.1 (1385 to 1631) |
| OMBIRR rev | ccatataaagaactaattgga | ||
| OMBIRL for | tcttgattactgttgcttga | Whole | NC_014760.1 (1003214 to 0001631) |
| OMBIRR rev | ccatataaagaactaattgga | ||
| OMAIRR for | gataagcaacgagatttttaag | IRR regions of | CU179680.1 (1371 to 1587); FP671138.1 (1371–1589) |
| OMAIRR rev | ttgaaacaacttcgataatgtca | ||
| IRROMA133 for | cattttaaaaagcggttttaaac | IRR133 region of MAG5632 (133 bp) | FP671138.1 (1402 to 1534) |
| IRR MA66 rev | attttccttaattaataaatatatg | ||
| IRROMA90 for | GGGCCCaaaaattgtattttttgttac | IRR90 region of MAG5632 (102 bp) | FP671138.1 (1463 to 1570) |
| IRROMA90 rev | GACGTCtaaaaaatttttgtttat | ||
| IRROMA 66for | aaaaattgtattttttgttacttatc | IRR66 region of MAG5632 (66 bp) | FP671138.1 (1469 to 1534) |
| IRROMA 66 rev | attttccttaattaataaatatatg | ||
| IRR OMA38 for | ttatccacaaattaacaaaacatatatttattaattaa | IRR38 region of MAG5632 (38 bp) | FP671138.1 (1490 to 1527) |
| IRR OMA38 rev | ttaattaataaatatatgttttgttaatttgtggataa | ||
| LAtetM for | gcagttatggaagggatacg | TetR screening PCR and probe (339 bp) | Sharma |
| LBtetM rev | ttcttgaatacaccgagcag | ||
| AmpR for | ccaatgcttaatcagtgagg | AmpR probe (862 bp) | Lee |
| AmpR rev | gtatgagtattcaacatttccg | ||
| GKp48 for | GCGGCCGCttgctgcttcatgtggtgat | Internal | NC_014760.1 (13995 to 14386) |
| GKp48 rev | CTGCAGgcgctgctttgtgagtaaatc | ||
| GKRE for | GCGGCCGCtgttgaaacattattaccaacaaaca | Internal | NC_014760.1 (648209 to 648670) |
| GKRE rev | CTGCAGtcgcccatgtgtatctaaacc | ||
| GKXer1 for | GCGGCCGCttgcagcatataaaaacatacttgc | Internal | NC_014760.1 (948459 to 948709) |
| GKXer1 rev | taCTGCAGtgtgcctttgtgagaataggtc | ||
| GKoriCrecA for | CTGCAGaagttcgaaaaaatccaattacacaaaatt |
| CP001873.1 (447765 to 449275) |
| GKoriCrecA rev | agGTCGACttattggcaatcttttaacttatttaatacc |
Upper case letters indicate the restriction endonuclease cleavage sites incorporated into the oligonucleotide primer
TetR = tetracycline resistance gene, AmpR = ampicillin resistance gene, typeII RE = type II restriction endonuclease gene
Fig 1Construction of homologous and heterologous oriC plasmids in a pGEM-T backbone.
(a) Solid lines indicate the amplified oriC regions, shaded rectangles indicate the location of AT rich clusters, while arrows indicate the location and nucleotide similarity of DnaA boxes to the consensus sequence: black 9, grey 8 and white 7, of 9 nucleotides identical. The whole oriC region containing dnaA with the left and right intergenic regions, as well as left (IRL) and right intergenic regions (IRR) wasamplified from M. bovis PG45 strain, while the IRR regions were also amplified from the M. agalactiae strains PG2 and 5632. The oriC plasmids marked with an asterisk (*) were developed in a pBluescript KS vector backbone, and had been used previously for transformation of M. agalactiae. (b) Amplified oriC products with varying oriC regions were ligated into the multicloning site of pGEM-T (Promega). (c) The tetracycline resistance gene (tetM) was then cloned into the SpeI site of these plasmids.
Transformation efficiency of homologous and heterologous oriC plasmids .
| Plasmid | Origin | Total size (kbp) | oriC region |
|
| ||||
|---|---|---|---|---|---|---|---|---|---|
| Total (CFU/ml) | TetR (CFU/ml) | Efficiency | Total (CFU/ml) | TetR (CFU/ml) | Efficiency | ||||
|
| MBOVPG45 | 7.1 | 1.8 kbp | 5.65×108 | 4024 | 7.12 ×10−6 | 4.33×1010 | 5 | 1.16 ×10−10 |
|
| MBOVPG45 | 5.5 | 247 bp | 5.55×108 | 17696 | 3.19 ×10−5 | 1.44×1010 | 1680 | 1.17 ×10−7 |
|
| MAG5632 | 9.5 | 1.3 kbp | 8.30×108 | 16 | 1.93 ×10−8 | 3.88×1010 | 2240 | 5.77 ×10−8 |
|
| MAG5632 | 5.9 | 700 bp | 6.90×108 | 96 | 1.39 ×10−7 | 7.50×109 | 9900 | 1.32 ×10−6 |
|
| MAG5632 | 5.5 | 219 bp | 6.10×108 | 1024 | 1.68×10−6 | 3.50×109 | 7160 | 2.05 ×10−6 |
|
| MAGPG2 | 5.5 | 217 bp | 1.02×109 | 214 | 2.09 ×10−7 | 3.14×1010 | 3760 | 1.20 ×10−7 |
|
| MBOVPG45 | 5.5 | 239 bp | 8.95×108 | 0 | 0 | NA | NA | NA |
#From one representative experiment in which these plasmids were used to transform M. bovis and M. agalactiae
* MBOVPG45, M. bovis strain PG45; MAG5632, M. agalactiae strain 5632; MAGPG2, M. agalactiae strain PG2
NA: Not attempted
aTotal concentration of viable organisms in colony forming units (CFU) without tetracycline selection
bConcentration of tetracycline resistant organisms after 2 h incubation at 37°C in non-selective broth
cTetracycline resistant CFU/ total viable CFU (transformation efficiency)
Fig 2Chromosomal integration of pWholeoriC45 plasmid.
Schematic diagram shows predicted integration of pWholeoriC45 plasmid into the genomic oriC region. Southern blot analysis of EcoRI-PstI digested DNA probed with DIG-labelled probes targeting oriC region (Panel A), ampR (Panel B) and tetM (Panel C). Lane 1, untransformed M. bovis; lane 2, pWholeoriC45 plasmid; lanes 3 & 4, passage (p)5 and p10 showing the extrachromosomal plasmid as well as the integrated form; lanes 5 and 6, p15 and p20 showing complete integration of the plasmid into the chromosome.
Fig 3Chromosomal integration and stability of heterologous plasmids in M. bovis.
Schematic representation of genomic oriC region, p20-1miniO/T and pMM21-7 plasmids and predicted organisation of the oriC region following integration of pMM21-7. Southern blot analysis of ClaI (panel A) or EcoRI (panel B) digested DNA probed with a DIG-labelled ampR probe. Lane 1, untransformed M. bovis; lane 2, pMM21-7; lane 3, clone 1 at passage 20; lane 4, clone 2 at p5 and lane 5, clone 2 at p10. Southern blot analysis of ClaI digested DNA probed with a DIG-labelled ampR probe (panel C). Lane 1, p20-1miniO/T; lane 2, untransformed M. bovis and lanes 3–7, p20-1miniO/T M. bovis transformants at p20.
Fig 4Stability of smaller oriC plasmids in M. bovis.
Schematic representation of genomic oriC region, IRR plasmids and predicted organisation of the oriC region following integration of different IRR plasmids. Southern blot analysis of EcoRI-PstI digested DNA probed with DIG-labelled probes targeting ampR (panel A) and oriC region (panel B). Smaller oriC plasmids were stable in M. bovis till p15-p20, but some integration appeared to have occurred in the oriC region. Lane 1, untransformed M. bovis; lanes, 2, 6 and 8, pIRR5632, pIRRPG2 and pIRR45, respectively. Lanes 3–5: pIRR5632 M. bovis transformants at p10, p15 and p20; lane 7, pIRRPG2 M. bovis transformants at p15; lanes 9–11, pIRR45 M. bovis transformants at p10, p15 and p20.